Six more personnel moves and a bevy of partnerships highlight the week that was.

An Orange County school district has announced it will no longer use the “Raiders” name for its athletic teams following ...

Truist Financial analyst Michael Lewis maintained a Hold rating on AvalonBay (AVB – Research Report) today and set a price target of $230.00.

This was the stock's sixth consecutive day of losses.

This was the stock's fifth consecutive day of losses.

The sale is expected to close on or around March 31. In addition, AVB entered into an agreement with BSR REIT, BSR Trust and certain holders of Class B units of BSR Trust to purchase six ...

Compelling results from a Mayo Clinic Phase I trial ("STOMP-I") led to the founding of Avobis Bio and primary endpoint results from the Phase II trial ("STOMP-II) of AVB-114 are expected in mid-2025.

ARLINGTON, Va., February 05, 2025--AvalonBay Communities, Inc. (NYSE: AVB) (the "Company") reported Earnings per Share – diluted ("EPS"), Funds from Operations ...